Attention-Deficit Hyperactivity Disorder (ADHD) Treatment and Sudden Death

Author： Besag Frank M.C.  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.32, Iss.11, 2009-11, pp. : 1097-1100

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The pharmacological treatment of attention-deficit hyperactivity disorder (ADHD) in adolescents is effective and relatively safe

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 23, Iss. 11, 2007-11 ,pp. : 9-12

Adis International

Access to resources Recommend Favorite

Modafinil: A Treatment Alternative for Children With Attention-Deficit/Hyperactivity Disorder (ADHD)

By  

Child and Adolescent Psychopharmacology News, Vol. 7, Iss. 6, 2002-12 ,pp. : 5-7

Guilford Publications Inc

Access to resources Recommend Favorite

Clinicians treating patients with bipolar disorders and attention-deficit hyperactivity disorder (ADHD) are more likely to identify bupropion as their treatment of choice than other antidepressants

By  

Inpharma, Vol. 1, Iss. 1545, 2006-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Role of Zinc in the Pathogenesis of Attention-Deficit Hyperactivity Disorder: Implications for Research and Treatment

By Lepping Peter  

CNS Drugs, Vol. 24, Iss. 9, 2010-09 ,pp. : 721-728

Adis International

Access to resources Recommend Favorite

Pharmacokinetic and Pharmacodynamic Drug Interactions in the Treatment of Attention-Deficit Hyperactivity Disorder

By Markowitz J.S.   Patrick K.S.  

Clinical Pharmacokinetics, Vol. 40, Iss. 10, 2001-01 ,pp. : 753-772

Adis International

Access to resources Recommend Favorite